Prognosis of Malignant Schwannoma The prognosis of malignant schwannoma, or malignant peripheral nerve sheath tumor (MPNST), is generally poor compared to other soft tissue sarcomas , due to its aggressive nature, high recurrence rate, and potential for distant metastasis
Cycle Protocol for Men Dosage: 2040 mcg per day Frequency: Daily, 57x/week Timing: Immediately post-workout (or fasted AM on rest days) Cycle Length: 46 weeks standard, up to 8 weeks with breaks Injection Site: Subcutaneous or intramuscular, often rotated (arms, legs, glutes) Goal Phases: Recomp, lean bulking, recovery/PCT Example Cycle (6 Weeks): Weeks 16: 30 mcg IGF-1 LR3 post-workout daily Paired with: Swolverine Whey Isolate, INTRA, and Collagen Stack potential: Low-dose testosterone, MK-677, or SARMs like LGD-4033 Cycle Protocol for Women Dosage: 1020 mcg per day Frequency: 45x/week preferred (to allow better hormonal regulation) Timing: Post-workout or morning before first meal Cycle Length: 34 weeks standard
Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism
CJC-1295 binds to the growth hormone-releasing hormone receptor while GHRP-2 acts on the growth hormone growth secretagogue/ghrelin receptor
